Video
Let's talk antitrust: Discussing recent cases and emerging competition issues
Recent cases and judgments have shone a light on some emerging themes and trends that companies will want to consider as part of their risk management framework.
Global | Publication | december 2024
On 22 October 2024, in a much-anticipated judgment (here), the English Court of Appeal dismissed appeals by the Kingdom of Spain (Spain) and the Republic of Zimbabwe (Zimbabwe) against two High Court decisions upholding the registration of ICSID awards against them under the UK’s Arbitration (International Investment Disputes) Act 1966 (the 1966 Act), the statute which implements the 1965 Convention of the Settlement of Investment Disputes between States and Nationals of Other States (the ICSID Convention).
The Court of Appeal’s decision is important because, while the High Court had rejected Spain’s and Zimbabwe’s respective sovereign immunity challenges, it did so “for entirely different reasons”, leading to considerable uncertainty as to the English law position.
Rejecting the High Court’s analysis in both decisions, the Court of Appeal has now confirmed that, as a matter of English law, foreign states that are the subject of adverse ICSID awards cannot rely on sovereign immunity to oppose the registration of such awards in England because they are taken to have waived immunity from suit by virtue of being a Contracting State to the ICSID Convention.
This decision brings welcome clarity as to the availability of state immunity objections upon registration of an ICSID award under the 1996 Act. The Court’s ruling that Article 54 of the ICSID Convention represents a waiver of immunity from suit also brings English law into accord with the laws of Australia, New Zealand and France (among others).
In 2021, both sets of claimant investors successfully applied to the English courts for registration of their respective ICSID awards under the 1996 Act which Spain and Zimbabwe then challenged on the basis of sovereign immunity.
To explain briefly, under the UK’s State Immunity Act 1978 (the SIA):
In Infrastructure Services v Spain1 (judgment here), on which we reported previously (here), the High Court dismissed the state’s sovereign immunity challenge on the grounds that:
In Border Timbers v Zimbabwe2 (judgment here), the High Court again dismissed the state’s application but found instead that:
As a result, when asked to consider very similar legal issues, the High Court had arrived at the same conclusion via very different analyses. Spain and Zimbabwe duly obtained leave to appeal.
Spain’s and Zimbabwe’s jointly-heard appeals gave rise to three key issues, namely:
Taking these in turn, the Court of Appeal concluded that:
Moreover, because, if it applies, state immunity from suit under Section 1(1) of the SIA represents a “barrier to the court assuming jurisdiction” rather than a defence to a claim over which the court has jurisdiction (as is the case for immunity from execution), registration of an ICSID award against a state under the 1966 Act inevitably engages questions of immunity.
Accordingly, by ratifying the ICSID Convention, Contracting States submit to the jurisdiction of the UK courts and cannot therefore “oppose the registration of the ICSID awards against them on the grounds of state immunity”.
The Court also found that, notwithstanding the High Court’s “novel approach” in Border Timbers v Zimbabwe, Article 54 was an express and sufficiently clear submission to the jurisdiction. In reaching this conclusion, the Court referred extensively to a recent decision of the High Court of Australia (in which Norton Rose Fulbright acted for the Infrastructure Services parties) addressing recognition of the ICSID award in Infrastructure Services v Spain against a similar legislative backdrop. The Court observed that “[a]s general rule it is desirable that international treaties should be interpreted by the courts of all the states uniformly” and, by interpreting Article 54 as a waiver of immunity from suit, brought English law into line with that of Australia, New Zealand, France and Malaysia.
The Court brushed aside concerns raised by Zimbabwe and Spain that interpreting Article 54 as an advance waiver of immunity from suit might result in similar language in Article III of the New York Convention being read in the same manner. The Court found that, while the relevant provisions are similar, they are not identical and there was no reason why interpretation of one treaty should necessarily influence another. In addition, while the point had not been argued before the English courts, it was unclear why such an interpretation would have the “dramatic” effect alleged because it was always open for states to “contest the validity of the arbitration agreement (and hence the enforcement of the award)”. The Court observed that Article III has been in fact held to contain a submission to the jurisdiction by a state in Australia (a matter in which Norton Rose Fulbright also acts).
The Court of Appeal’s judgment confirms that, while the SIA applies to ICSID enforcement proceedings (as an exercise of the English courts’ adjudicative jurisdiction), states cannot rely on immunity under Section 1(1) at the registration stage because Article 54 of the ICSID Convention amounts a submission to the jurisdiction falling with the exception in Section 2 of the SIA.
The Court of Appeal’s judgment resolves the contradictions in the lower court’s decisions. It also gives comfort to investors seeking to register ICSID awards against states in England. That said, as the Court declined to enter the debate as to Spain’s “intra-EU” objection, Zimbabwe’s “non-immunity defences” and the role that immunity is likely to play when proceedings progress to execution against the states’ property, this decision is unlikely to be the final word in either case.
Video
Recent cases and judgments have shone a light on some emerging themes and trends that companies will want to consider as part of their risk management framework.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023